EMEA-000144-PIP01-07-M05

Key facts

Invented name
Emend
Active substance
Aprepitant
Therapeutic area
Oncology
Decision number
P/0008/2014
PIP number
EMEA-000144-PIP01-07-M05
Pharmaceutical form(s)
  • Powder for suspension
  • hard capsule
Condition(s) / indication(s)
Prevention of nausea and vomiting
Route(s) of administration
Oral use
Contact for public enquiries
Merck Sharp & Dohme Ltd
United Kingdom
E-mail: pip.information@merck.com
Tel. +31 412663179
Fax +31 412662571
Decision type
PM: decision on the application for modification of an agreed PIP
Compliance procedure number
EMEA-C-000144-PIP01-07-M05
Compliance opinion date
10/10/2014
Compliance outcome
positive

Decision

How useful was this page?

Add your rating